Skip to main content
COSMOS Pharmaceutical Corporation logo

COSMOS Pharmaceutical Corporation — Investor Relations & Filings

Ticker · 3349 ISIN · JP3298400007 T Wholesale and retail trade
Filings indexed 62 across all filing types
Latest filing 2026-01-14 Regulatory Filings
Country JP Japan
Listing T 3349

About COSMOS Pharmaceutical Corporation

https://www.cosmospc.co.jp/english/

COSMOS Pharmaceutical Corporation is a retail company that operates a chain of large-format drugstores. The company's business is centered on a unique "small-catchment-area mega drugstore" model, which establishes large stores in areas with small population catchments. These stores function as "super-sized convenience stores," offering one-stop shopping for a wide range of products, including pharmaceuticals, cosmetics, daily necessities, and a comprehensive selection of food items. A core tenet of its strategy is the "Everyday Low Price" promise, which eschews temporary sales and loyalty programs in favor of consistent value to build customer trust. The company also develops its own private brand products to offer quality at a low cost. It pursues a high-density store deployment strategy to achieve dominant market share and operational efficiencies in targeted regions.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 1% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act. It serves as an officer certification regarding the accuracy of a previously filed semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type like an interim/semi-annual report. H1 44
2026-01-14 Japanese
半期報告書-第44期(2025/06/01-2026/05/31)
Interim / Quarterly Report Classification · 1% confidence The document is a '半期報告書' (Semi-Annual Report) filed by COSMOS Pharmaceutical Corporation in Japan. It contains detailed financial statements, management analysis, and audit information for the interim period ending November 30, 2025. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 44
2026-01-14 Japanese
確認書
Audit Report / Information Classification · 1% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under Article 24-4-2 of the Financial Instruments and Exchange Act of Japan. This is a mandatory document filed alongside the Annual Securities Report (Yukashoken Hokokusho) in Japan, where executives certify the accuracy of the report's contents. Since it is a regulatory filing required by law to accompany the annual report but is not the annual report itself, and does not fit into other specific categories like M&A or dividends, it falls under the general regulatory filings category. FY 2025
2025-08-28 Japanese
有価証券報告書-第43期(2024/06/01-2025/05/31)
Annual Report Classification · 1% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the standard annual financial report filed by public companies in Japan under the Financial Instruments and Exchange Act. It contains comprehensive financial statements, management discussion, and business information for the fiscal year ending May 31, 2025. This corresponds to the definition of an Annual Report (10-K). FY 2025
2025-08-28 Japanese
確認書
Regulatory Filings Classification · 1% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act. It serves as an officer certification regarding the accuracy of the company's interim report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a report (like an interim report), should be classified as Regulatory Filings (RNS) rather than the report itself. H1 43
2025-01-14 Japanese
半期報告書-第43期(2024/06/01-2025/05/31)
Interim / Quarterly Report Classification · 1% confidence The document is a '半期報告書' (Semi-Annual Report) for COSMOS Pharmaceutical Corporation, covering the period from June 1, 2024, to November 30, 2024. It includes detailed financial statements (balance sheets, etc.), management analysis, and audit review information. This fits the definition of an Interim/Quarterly Report (IR) as it provides comprehensive financial data for a period shorter than a full fiscal year. H1 2025
2025-01-14 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.